Description
Flux GHRP-6 + GHRP-2 + HEXARELIN 16 mg x 5 Vials – British Dispensary is a combination research product containing three synthetic peptides studied for their activity at the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.
Each vial contains a total of 16 mg of peptide blend, made up of 6 mg GHRP-6, 5 mg GHRP-2, and 5 mg Hexarelin. These compounds are studied in laboratory research involving growth hormone release, ghrelin-receptor signalling, and related endocrine pathways.
Composition Per Vial
| Ingredient | Amount |
|---|---|
| GHRP-6 | 6 mg |
| GHRP-2 | 5 mg |
| Hexarelin | 5 mg |
| Total | 16 mg |
Product Benefits and Research Areas
- Growth Hormone Signalling Research: All three peptides are studied for their ability to activate pathways associated with growth hormone secretion.
- Ghrelin Receptor Studies: GHRP-6, GHRP-2, and Hexarelin interact with the GHS-R1a receptor, making the blend relevant to receptor-signalling research.
- Endocrine Research: Investigated in experimental models examining growth hormone regulation and related hormonal responses.
- Peptide Comparison Studies: The three compounds provide different research profiles for studying growth hormone secretagogue activity.
- Metabolic Pathway Research: Relevant to laboratory investigations of endocrine and metabolic signalling.
Understanding the Three Peptides
GHRP-6: A synthetic growth hormone-releasing peptide studied for its activity at the ghrelin receptor. It is also associated with appetite-related signalling in experimental research.
GHRP-2: A synthetic growth hormone secretagogue investigated for its effects on growth hormone release and related endocrine pathways.
Hexarelin: A potent synthetic growth hormone-releasing peptide studied for its interaction with the ghrelin receptor and its effects on growth hormone signalling.
Important Safety Information
This combination should be regarded as an experimental research product, not an established treatment or proven bodybuilding supplement. The safety and effectiveness of combining these three peptides in humans have not been established. Research on individual compounds does not establish the safety of this blend. Potential concerns include changes in hormone levels, appetite, glucose regulation, and other endocrine effects. It should not be marketed as approved for human use or self-administration.
Product Details: 16 mg total peptide blend per vial (6 mg GHRP-6 + 5 mg GHRP-2 + 5 mg Hexarelin), supplied as a pack of 5 vials.
Reviews
There are no reviews yet.